Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cerami

Showing results (1-10 of 362) with videos related to

Pageof 37
Sort By:
The American Journal of Medicine|September 1, 1978
Drug development for "orphan" diseasesA Cerami
The New England Journal of Medicine|June 24, 1976
Editorial: "Propper" use of desferrioxamineA Cerami
Journal of the American Geriatrics Society|September 1, 1985
Hypothesis. Glucose as a mediator of agingA Cerami
Annals of the New York Academy of Sciences|November 29, 1974
Review of the development of cyanate as a drug in the treatment of sickle cell anemiaA Cerami
Blood Purification|January 1, 1993
Tumor necrosis factor as a mediator of shock, cachexia and inflammationA Cerami
Progress in Clinical and Biological Research|January 1, 1985
Accumulation of advanced glycosylation endproducts on proteins and nucleic acids: role in ageingA Cerami
The New England Journal of Medicine|October 19, 1972
Cyanate as an inhibitor of red-cell sicklingA Cerami
Journal of Internal Medicine|December 17, 2010
The value of failure: the discovery of TNF and its natural inhibitor erythropoietinA Cerami
Seminars in Hematology|August 28, 2001
Beyond erythropoiesis: novel applications for recombinant human erythropoietinA Cerami
Clinical Immunology and Immunopathology|January 1, 1992
Inflammatory cytokinesA Cerami
Pageof 37

Showing results (1-10 of 362) with videos related to

Sort By:
Pageof 37
The American Journal of Medicine|September 1, 1978
Drug development for "orphan" diseasesA Cerami
The New England Journal of Medicine|June 24, 1976
Editorial: "Propper" use of desferrioxamineA Cerami
Journal of the American Geriatrics Society|September 1, 1985
Hypothesis. Glucose as a mediator of agingA Cerami
Annals of the New York Academy of Sciences|November 29, 1974
Review of the development of cyanate as a drug in the treatment of sickle cell anemiaA Cerami
Blood Purification|January 1, 1993
Tumor necrosis factor as a mediator of shock, cachexia and inflammationA Cerami
Progress in Clinical and Biological Research|January 1, 1985
Accumulation of advanced glycosylation endproducts on proteins and nucleic acids: role in ageingA Cerami
The New England Journal of Medicine|October 19, 1972
Cyanate as an inhibitor of red-cell sicklingA Cerami
Journal of Internal Medicine|December 17, 2010
The value of failure: the discovery of TNF and its natural inhibitor erythropoietinA Cerami
Seminars in Hematology|August 28, 2001
Beyond erythropoiesis: novel applications for recombinant human erythropoietinA Cerami
Clinical Immunology and Immunopathology|January 1, 1992
Inflammatory cytokinesA Cerami
Pageof 37